Date | Programmes | Podcast Title | |
---|---|---|---|
17-Mar-22 |
Evening Edition (5:00 PM) |
Popek Popek Parlimen: Where Is Tengku Zafrul?
|
|
07-Feb-22 |
Morning Brief (8:30 AM) |
PICKids: A Thing Of Concern For The Kids?
Dr Khoo Yoong Khean, Managing Editor, Malaysian Medical Gazette |
|
04-Aug-21 |
Health & Living (1:30 PM) |
H&L Webinar 2021 #4: Why Vaccination Matters For Your Child
Datuk Dr Zulkifli Ismail, Chairman, Immunise4Life |
|
29-Mar-21 |
Pressing Matters (9:37 AM) |
Framing Matters: Media Messaging and Vaccines in Malaysia
Dr. Wan Norshira Wan Mohamed Ghazali, Assistant Professor, International Islamic University Malaysia |
|
25-Feb-21 |
Morning Brief (7:47 AM) |
Dealing With Vaccine Skepticism
Dr Helmy Haja Mydin, Internal Medicine Specialist, Pantai Hospital Kuala Lumpur |
|
18-Feb-21 |
Evening Edition (6:30 PM) |
Gaining The Trust Of Undocumented Migrants
Adrian Pereira, Executive Director of the North South Initiative |
|
04-Dec-20 |
Market Watch (9:17 AM) |
Is Singapore's Rally Sustainable?
Geoff Howie, Market Strategist, Singapore Exchange |
|
25-Nov-20 |
Evening Edition (5:00 PM) |
Popek Popek Parlimen: JKOM To Replace JASA
|
|
25-Nov-20 |
The Daily Digest (2:00 PM) |
Calling on Governments to Waive Patents on COVID-19 Vaccines
Leena Menghaney, Regional Head (South Asia), Médecins Sans Frontières Access Campaign |
|
25-Nov-20 |
Market Watch (7:07 AM) |
Giving Big Tech In China A Break
Jack Kouzi, Director of Strategy, VFS Group |
|
24-Nov-20 |
Evening Edition (5:40 PM) |
Too Many Vaccine Options A Bad Thing?
|
|
11-Nov-20 |
The Daily Digest (2:00 PM) |
Breaking Down Pfizer Vaccine’s Early Results
Prof Dr Sanjay Rampal, Epidemiologist, University of Malaya |
|
11-Nov-20 |
Morning Brief (7:37 AM) |
Pfizer Vaccine: What Are The Hurdles Ahead?
Dale Fisher, Professor of Infectious Diseases, National University of Singapore |
|
10-Nov-20 |
Evening Edition (5:40 PM) |
How Much Should A Vaccine Cost?
Benjamin Cowling, Professor of Infectious Disease Epidemiology, University of Hong Kong |
|
21-Oct-20 |
Morning Brief (7:37 AM) |
Vaccine for Malaysia Only in Q2 2021?
Benjamin Cowling, Professor of Infectious Disease Epidemiology, University of Hong Kong |
|
14-Oct-20 |
Health & Living (4:00 PM) |
Public Health #35: COVAX – What This Means for Malaysia's Access to a COVID-19 Vaccine
Azrul Mohd Khalib, CEO, Galen Centre for Health & Social Policy |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Vishnu Varathan, Head of Economics & Strategy, Mizuho Banktells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Dr. Deborah K. Elms from the Hinrich Foundation discusses the latest tensions between the US and China and what they could mean for global trade.
Morning Brief
Alina Amir, CEO and Co-founder of Arus Academy discusses institutional readiness in making school a safer place.
The Breakfast Grille
Datuk Ahmad Shalimin Ahmad Shaffie, Chairman of EMGS discusses whether Malaysia can be a leading education hub in Asia.
Morning Brief
Marhalim Abas, Freelance Defence Writer weighs in on Budget 2026, where the Ministry of Defence gets RM21.7 billion, up 3% from last year.
Morning Brief
We dive into the local and international news that matters to you.
Opening Bell
(REPEAT) Vishnu Varathan, Head of Economics & Strategy, Mizuho Banktells us where international markets are heading.
Opening Bell
Toh Woo Kim, Senior Analyst, Hong Leong Investment Bank Research discusses how Budget 2026 might affect the tech sector.
Ringgit & Sense
Thanneermalai Somasundaram, Managing Director of Thannees Tax Consulting Services discusses tax reliefs and goodies from Budget 2026.
Open For Business
NanoSkunkWorkX (nSWX)
Tech Talk
Prashant Kumar, Founder, Entermind
Enterprise Explores
Azri Jamaludin and Shahrizal Denci, Directors, Bantu Tani
The Breakfast Grille Repeat
Our flagship show, we feature both game-changers and groundbreakers in the hot seat.
Beyond the Ballot Box
TBC
Health & Living
Focal therapies for prostate cancer promise fewer side effects for men, but is it suitable for every patient? We try to understand more about these minimally-invasive therapies.
Top 5 at 5
Talkback Thursday
BBC World Service
Are atoms permanent? Tune in as the Crowd Science team tries to find the answers.